IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer.
Amisaki M, Zebboudj A, Yano H, Zhang SL, Payne G, Chandra AK, Yu R, Guasp P, Sethna ZM, Ohmoto A, Rojas LA, Cheng C, Waters T, Solovyov A, Martis S, Doane AS, Reiche C, Bruno EM, Milighetti M, Soares K, Odgerel Z, Moral JA, Zhao JN, Gönen M, Gardner R, Tumanov AV, Khan AG, Vergnolle O, Nyakatura EK, Lorenz IC, Baca M, Patterson E, Greenbaum B, Artis D, Merghoub T, Balachandran VP.
Amisaki M, et al. Among authors: rojas la.
Nature. 2025 Jan 15. doi: 10.1038/s41586-024-08426-5. Online ahead of print.
Nature. 2025.
PMID: 39814891